Given the rise of peptide and protein therapeutics in the pharmaceutical landscape, identifying the right delivery strategies that are patient-friendly and can be used over broad dose ranges has always been important considerations for the discovery and development of these therapeutic modalities. In recent years, polymeric hydrogels have emerged as potential drug delivery vehicles for peptides and proteins owing to their advantageous properties, including high water content, tunable viscoelasticity, and biocompatibility, which allow bioactive molecules to be protected against degradation and released from the hydrogel matrix in a controlled manner over an extended period of time.

Dr Yingkai Laing from Merck & Co discusses this further and shares some examples of his groups work. In this study, a series of injectable, thermo-responsive hydrogel formulations were evaluated as controlled delivery systems for peptides and proteins. These hydrogel formulations were prepared using concentrated solutions of thermo-gelling PEG/polyester block copolymers, which can undergo temperature-induced sol-gel transitions and spontaneously solidify into hydrogel near the body temperature. Additionally, the thermal gelation of these polymers was also combined with covalent crosslinking to develop in situ forming yet highly stable hydrogels for extended release of macromolecular cargos. Utilizing insulin peptide analogues as model proteins, the delivery and therapeutic efficacy of these formulations in vivo were also studied in diabetic minipig and mouse models via subcutaneous administration. Taken together, these injectable, thermo-responsive hydrogel formulations presented a promising approach for the controlled and sustained delivery of biomacromolecules, which suggests significant potential in developing long-acting parenteral formulations of protein therapeutics to improve patient’s comfort, convenience, and compliance.

 

 

Need Access to More While Working Remotely? Check out Curtis & Coulter’s Virtual Drug Product Development Content Toolkit

While you are working remotely, we can help you keep up-to-date with the advancing drug product development landscape, by providing you and your team access to innovative drug development strategies and approaches from the comfort of working from home. Stay in the know and relevent with 3 year’s worth (115+) leading industry presentations and case studies from our popular:

 

  • Controlled & Modified Drug Release Summits
  • Peptide Drug Design & Delivery Summits
  • Global Drug Bioavailability Enhancement Summits

Additionally, open the door to connecting digitally with our previous drug product development participants and innovators instantly, as well as explore opportunities to share your digital content and technology to our wider audience. Whether you are a pharma/biotech company looking for new relevant drug product development content, or a consultant/solution provider looking to network we have a digital remote working solution for you! Click below to find out more.

Pin It on Pinterest

Share This

Share this with a friend or colleague!